Accessibility Menu
Clene logo

Clene

(NASDAQ) CLNN

Current Price$5.47
Market Cap$69.64M
Since IPO (2018)-97%
5 Year-97%
1 Year+26%
1 Month-24%

Clene Financials at a Glance

Market Cap

$69.64M

Revenue (TTM)

$134.00K

Net Income (TTM)

-$33.51M

EPS (TTM)

-$3.21

P/E Ratio

-1.70

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$5.47

Volume

3,600

Open

$5.77

Previous Close

$5.47

Daily Range

$5.41 - $5.77

52-Week Range

$3.25 - $13.50

Estimated Earnings Date

Aug 13, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clene

Industry

Biotechnology

Employees

79

CEO

Robert Dee Etherington, MBA

Headquarters

Salt Lake City, UT 84121, US

CLNN Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-155%

Net Income Margin

-250%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-2%

Earnings Yield

-58.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$69.64M

Shares Outstanding

12.78M

Volume

3.60K

Avg. Volume

485.89K

Financials (TTM)

Gross Profit

$157.00K

Operating Income

-$23.08M

EBITDA

-$21.59M

Operating Cash Flow

-$18.55M

Capital Expenditure

-$39.00K

Free Cash Flow

-$18.59M

Cash & ST Invst.

$5.19M

Total Debt

$21.67M

Clene Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$15.00K

-81.5%

Gross Profit

-$340.00K

-657.4%

Gross Margin

-22.67%

N/A

Market Cap

$69.64M

N/A

Market Cap/Employee

$928.56K

N/A

Employees

75

N/A

Net Income

-$8.09M

-977.4%

EBITDA

-$1.71M

-753.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

-$16.11M

-45.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$54.00K

+42.1%

Long Term Debt

$19.36M

+15.0%

Short Term Debt

$2.69M

-34.4%

Return on Assets

-1.55%

N/A

Return on Invested Capital

-1.39%

N/A

Free Cash Flow

-$4.53M

+9.6%

Operating Cash Flow

-$4.53M

+9.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PLRXPliant Therapeutics, Inc.
$1.15-1.71%
COYACoya Therapeutics, Inc.
$4.42-9.24%
CNTBConnect Biopharma Holdings Limited
$2.17-5.65%
ORMPOramed Pharmaceuticals Inc.
$3.71-2.62%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$14.38-0.13%
TQQQProShares Trust - ProShares UltraPro Qqq
$73.05-0.14%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.19+0.14%
IBITiShares Bitcoin Trust
$34.14-0.05%

Questions About CLNN

What is the current price of Clene?

Clene is trading at $5.47 per share.

What is the 52-week range for Clene?

Over the past 52 weeks, Clene has traded between $3.25 and $13.50.

How much debt does Clene have?

As of the most recent reporting period, Clene reported total debt of $22.05M.

How much cash does Clene have on hand?

Clene reported $5.94M in cash and cash equivalents in its most recent financial results.

What is Clene’s dividend yield?

Clene does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.